TREATMENTS &
RESEARCH
latest
treatment
information
here.
Dr. Huntley's
Diagnosis
Checklist
See what questions
a doctor would ask.
1 per 5,000 - 7,000 people suffer from alpha-1 antitrypsin deficiency in North America, Genetics Home Reference website
approx 1 in 5,000 or 0.02% or 54,400 people in USA [about data]
WARNING! EXTRAPOLATION ONLY! NOT BASED ON COUNTRY-SPECIFIC DATA SOURCES. The following table attempts to extrapolate the above prevalence rate for Alpha 1-Antitrypsin Deficiency to the populations of various countries and regions. These prevalence extrapolations for Alpha 1-Antitrypsin Deficiency are only estimates, based on applying the prevalence rates from the US (or a similar country) to the population of other countries, and therefore may have very limited relevance to the actual prevalence of Alpha 1-Antitrypsin Deficiency in any region:
| Country/Region | Extrapolated Prevalence | Population Estimated Used |
| Alpha 1-Antitrypsin Deficiency in North America (Extrapolated Statistics) | ||
| USA | 58,731 | 293,655,4051 |
| Canada | 6,501 WARNING! (Details) | 32,507,8742 |
| Mexico | 20,991 WARNING! (Details) | 104,959,5942 |
| Alpha 1-Antitrypsin Deficiency in Central America (Extrapolated Statistics) | ||
| Belize | 54 WARNING! (Details) | 272,9452 |
| Guatemala | 2,856 WARNING! (Details) | 14,280,5962 |
| Nicaragua | 1,071 WARNING! (Details) | 5,359,7592 |
| Alpha 1-Antitrypsin Deficiency in Caribbean (Extrapolated Statistics) | ||
| Puerto Rico | 779 WARNING! (Details) | 3,897,9602 |
| Alpha 1-Antitrypsin Deficiency in South America (Extrapolated Statistics) | ||
| Brazil | 36,820 WARNING! (Details) | 184,101,1092 |
| Chile | 3,164 WARNING! (Details) | 15,823,9572 |
| Colombia | 8,462 WARNING! (Details) | 42,310,7752 |
| Paraguay | 1,238 WARNING! (Details) | 6,191,3682 |
| Peru | 5,508 WARNING! (Details) | 27,544,3052 |
| Venezuela | 5,003 WARNING! (Details) | 25,017,3872 |
| Alpha 1-Antitrypsin Deficiency in Northern Europe (Extrapolated Statistics) | ||
| Denmark | 1,082 WARNING! (Details) | 5,413,3922 |
| Finland | 1,042 WARNING! (Details) | 5,214,5122 |
| Iceland | 58 WARNING! (Details) | 293,9662 |
| Sweden | 1,797 WARNING! (Details) | 8,986,4002 |
| Alpha 1-Antitrypsin Deficiency in Western Europe (Extrapolated Statistics) | ||
| Britain (United Kingdom) | 12,054 WARNING! (Details) | 60,270,708 for UK2 |
| Belgium | 2,069 WARNING! (Details) | 10,348,2762 |
| France | 12,084 WARNING! (Details) | 60,424,2132 |
| Ireland | 793 WARNING! (Details) | 3,969,5582 |
| Luxembourg | 92 WARNING! (Details) | 462,6902 |
| Monaco | 6 WARNING! (Details) | 32,2702 |
| Netherlands (Holland) | 3,263 WARNING! (Details) | 16,318,1992 |
| United Kingdom | 12,054 WARNING! (Details) | 60,270,7082 |
| Wales | 583 WARNING! (Details) | 2,918,0002 |
| Alpha 1-Antitrypsin Deficiency in Central Europe (Extrapolated Statistics) | ||
| Austria | 1,634 WARNING! (Details) | 8,174,7622 |
| Czech Republic | 249 WARNING! (Details) | 1,0246,1782 |
| Germany | 16,484 WARNING! (Details) | 82,424,6092 |
| Hungary | 2,006 WARNING! (Details) | 10,032,3752 |
| Liechtenstein | 6 WARNING! (Details) | 33,4362 |
| Poland | 7,725 WARNING! (Details) | 38,626,3492 |
| Slovakia | 1,084 WARNING! (Details) | 5,423,5672 |
| Slovenia | 402 WARNING! (Details) | 2,011,473 2 |
| Switzerland | 1,490 WARNING! (Details) | 7,450,8672 |
| Alpha 1-Antitrypsin Deficiency in Eastern Europe (Extrapolated Statistics) | ||
| Belarus | 2,062 WARNING! (Details) | 10,310,5202 |
| Estonia | 268 WARNING! (Details) | 1,341,6642 |
| Latvia | 461 WARNING! (Details) | 2,306,3062 |
| Lithuania | 721 WARNING! (Details) | 3,607,8992 |
| Russia | 28,794 WARNING! (Details) | 143,974,0592 |
| Ukraine | 9,546 WARNING! (Details) | 47,732,0792 |
| Alpha 1-Antitrypsin Deficiency in the Southwestern Europe (Extrapolated Statistics) | ||
| Azerbaijan | 1,573 WARNING! (Details) | 7,868,3852 |
| Georgia | 938 WARNING! (Details) | 4,693,8922 |
| Portugal | 2,104 WARNING! (Details) | 10,524,1452 |
| Spain | 8,056 WARNING! (Details) | 40,280,7802 |
| Alpha 1-Antitrypsin Deficiency in Southern Europe (Extrapolated Statistics) | ||
| Greece | 2,129 WARNING! (Details) | 10,647,5292 |
| Italy | 11,611 WARNING! (Details) | 58,057,4772 |
| Alpha 1-Antitrypsin Deficiency in the Southeastern Europe (Extrapolated Statistics) | ||
| Albania | 708 WARNING! (Details) | 3,544,8082 |
| Bosnia and Herzegovina | 81 WARNING! (Details) | 407,6082 |
| Bulgaria | 1,503 WARNING! (Details) | 7,517,9732 |
| Croatia | 899 WARNING! (Details) | 4,496,8692 |
| Macedonia | 408 WARNING! (Details) | 2,040,0852 |
| Romania | 4,471 WARNING! (Details) | 22,355,5512 |
| Serbia and Montenegro | 2,165 WARNING! (Details) | 10,825,9002 |
| Alpha 1-Antitrypsin Deficiency in Northern Asia (Extrapolated Statistics) | ||
| Mongolia | 550 WARNING! (Details) | 2,751,3142 |
| Alpha 1-Antitrypsin Deficiency in Central Asia (Extrapolated Statistics) | ||
| Kazakhstan | 3,028 WARNING! (Details) | 15,143,7042 |
| Tajikistan | 1,402 WARNING! (Details) | 7,011,556 2 |
| Uzbekistan | 5,282 WARNING! (Details) | 26,410,4162 |
| Alpha 1-Antitrypsin Deficiency in Eastern Asia (Extrapolated Statistics) | ||
| China | 259,769 WARNING! (Details) | 1,298,847,6242 |
| Hong Kong s.a.r. | 1,371 WARNING! (Details) | 6,855,1252 |
| Japan | 25,466 WARNING! (Details) | 127,333,0022 |
| Macau s.a.r. | 89 WARNING! (Details) | 445,2862 |
| North Korea | 4,539 WARNING! (Details) | 22,697,5532 |
| South Korea | 9,646 WARNING! (Details) | 48,233,7602 |
| Taiwan | 4,549 WARNING! (Details) | 22,749,8382 |
| Alpha 1-Antitrypsin Deficiency in Southwestern Asia (Extrapolated Statistics) | ||
| Turkey | 13,778 WARNING! (Details) | 68,893,9182 |
| Alpha 1-Antitrypsin Deficiency in Southern Asia (Extrapolated Statistics) | ||
| Afghanistan | 5,702 WARNING! (Details) | 28,513,6772 |
| Bangladesh | 28,268 WARNING! (Details) | 141,340,4762 |
| Bhutan | 437 WARNING! (Details) | 2,185,5692 |
| India | 213,014 WARNING! (Details) | 1,065,070,6072 |
| Pakistan | 31,839 WARNING! (Details) | 159,196,3362 |
| Sri Lanka | 3,981 WARNING! (Details) | 19,905,1652 |
| Alpha 1-Antitrypsin Deficiency in Southeastern Asia (Extrapolated Statistics) | ||
| East Timor | 203 WARNING! (Details) | 1,019,2522 |
| Indonesia | 47,690 WARNING! (Details) | 238,452,9522 |
| Laos | 1,213 WARNING! (Details) | 6,068,1172 |
| Malaysia | 4,704 WARNING! (Details) | 23,522,4822 |
| Philippines | 17,248 WARNING! (Details) | 86,241,6972 |
| Singapore | 870 WARNING! (Details) | 4,353,8932 |
| Thailand | 12,973 WARNING! (Details) | 64,865,5232 |
| Vietnam | 16,532 WARNING! (Details) | 82,662,8002 |
| Alpha 1-Antitrypsin Deficiency in the Middle East (Extrapolated Statistics) | ||
| Gaza strip | 264 WARNING! (Details) | 1,324,9912 |
| Iran | 13,500 WARNING! (Details) | 67,503,2052 |
| Iraq | 5,074 WARNING! (Details) | 25,374,6912 |
| Israel | 1,239 WARNING! (Details) | 6,199,0082 |
| Jordan | 1,122 WARNING! (Details) | 5,611,2022 |
| Kuwait | 451 WARNING! (Details) | 2,257,5492 |
| Lebanon | 755 WARNING! (Details) | 3,777,2182 |
| Saudi Arabia | 5,159 WARNING! (Details) | 25,795,9382 |
| Syria | 3,603 WARNING! (Details) | 18,016,8742 |
| United Arab Emirates | 504 WARNING! (Details) | 2,523,9152 |
| West Bank | 462 WARNING! (Details) | 2,311,2042 |
| Yemen | 4,004 WARNING! (Details) | 20,024,8672 |
| Alpha 1-Antitrypsin Deficiency in Northern Africa (Extrapolated Statistics) | ||
| Egypt | 15,223 WARNING! (Details) | 76,117,4212 |
| Libya | 1,126 WARNING! (Details) | 5,631,5852 |
| Sudan | 7,829 WARNING! (Details) | 39,148,1622 |
| Alpha 1-Antitrypsin Deficiency in Western Africa (Extrapolated Statistics) | ||
| Congo Brazzaville | 599 WARNING! (Details) | 2,998,0402 |
| Ghana | 4,151 WARNING! (Details) | 20,757,0322 |
| Liberia | 678 WARNING! (Details) | 3,390,6352 |
| Niger | 2,272 WARNING! (Details) | 11,360,5382 |
| Nigeria | 3,550 WARNING! (Details) | 12,5750,3562 |
| Senegal | 2,170 WARNING! (Details) | 10,852,1472 |
| Sierra leone | 1,176 WARNING! (Details) | 5,883,8892 |
| Alpha 1-Antitrypsin Deficiency in Central Africa (Extrapolated Statistics) | ||
| Central African Republic | 748 WARNING! (Details) | 3,742,4822 |
| Chad | 1,907 WARNING! (Details) | 9,538,5442 |
| Congo kinshasa | 11,663 WARNING! (Details) | 58,317,0302 |
| Rwanda | 1,647 WARNING! (Details) | 8,238,6732 |
| Alpha 1-Antitrypsin Deficiency in Eastern Africa (Extrapolated Statistics) | ||
| Ethiopia | 14,267 WARNING! (Details) | 71,336,5712 |
| Kenya | 6,596 WARNING! (Details) | 32,982,1092 |
| Somalia | 1,660 WARNING! (Details) | 8,304,6012 |
| Tanzania | 7,214 WARNING! (Details) | 36,070,7992 |
| Uganda | 5,278 WARNING! (Details) | 26,390,2582 |
| Alpha 1-Antitrypsin Deficiency in Southern Africa (Extrapolated Statistics) | ||
| Angola | 2,195 WARNING! (Details) | 10,978,5522 |
| Botswana | 327 WARNING! (Details) | 1,639,2312 |
| South Africa | 8,889 WARNING! (Details) | 44,448,4702 |
| Swaziland | 233 WARNING! (Details) | 1,169,2412 |
| Zambia | 2,205 WARNING! (Details) | 11,025,6902 |
| Zimbabwe | 734 WARNING! (Details) | 1,2671,8602 |
| Alpha 1-Antitrypsin Deficiency in Oceania (Extrapolated Statistics) | ||
| Australia | 3,982 WARNING! (Details) | 19,913,1442 |
| New Zealand | 798 WARNING! (Details) | 3,993,8172 |
| Papua New Guinea | 1,084 WARNING! (Details) | 5,420,2802 |
WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries. These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Alpha 1-Antitrypsin Deficiency are typically based on US, UK, Canadian or Australian prevalence or incidence statistics, which are then extrapolated using only the population of the other country. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Alpha 1-Antitrypsin Deficiency statistics below refer to. The extrapolation does not use data sources or statistics about any country other than its population. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Alpha 1-Antitrypsin Deficiency in that region. These statistics are presented only in the hope that they may be interesting to some people.
The word 'prevalence' of Alpha 1-Antitrypsin Deficiency usually means the estimated population of people who are managing Alpha 1-Antitrypsin Deficiency at any given time (i.e. people with Alpha 1-Antitrypsin Deficiency). The term 'incidence' of Alpha 1-Antitrypsin Deficiency means the annual diagnosis rate, or the number of new cases of Alpha 1-Antitrypsin Deficiency diagnosed each year (i.e. getting Alpha 1-Antitrypsin Deficiency). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.